SEC Form 4 · accession 0001179110-19-003511
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Goldstein
Director
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2019 | M | 20,500 | $8.71 | A | 21,418 | D | |
| Common StockF1 | Mar 5, 2019 | S | 10,500 | $63.33 | D | 10,918 | D | |
| Common StockF2 | Mar 5, 2019 | S | 10,000 | $63.47 | D | 918 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $8.71 | Mar 5, 2019 | M | 20,500 | D | — | Feb 25, 2025 | Common Stock | 20,500 | 13,105 | D |
Explanation of responses
- F1Represents the weighted average price of transactions ranging from $63.25 to $63.61. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Represents the weighted average price of transactions ranging from $63.39 to $63.56. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.